SciBase's EIS Technology Selected as Primary Endpoint in NIH Skin Barrier Study
STOCKHOLM, Oct. 15, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leader in AI-based devices for detection and prevention in dermatology, today announces that a new study will be initiated in a collaboration between NIH (National Institute of Health, US) and the Swiss...
Read original article on All News Releases →